Endothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries

scientific article published on November 2013

Endothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/BPH.12332
P932PMC publication ID3838695
P698PubMed publication ID23941276

P2093author name stringJ G R De Mey
M G Compeer
G M J Janssen
P2860cites workThe human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genesQ24339000
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potentialQ24656131
International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclatureQ28201563
Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophilsQ28308243
Evidence that ET-1, but not ET-3 and S6b, ET(A)-receptor mediated contractions in isolated rat mesenteric arteries are modulated by co-activation of ET(B) receptorsQ28343934
Calcitonin gene-related peptide selectively relaxes contractile responses to endothelin-1 in rat mesenteric resistance arteriesQ28581000
A novel potent vasoconstrictor peptide produced by vascular endothelial cellsQ29620540
Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II.Q30304611
NO-independent regulatory site on soluble guanylate cyclaseQ32165040
Vascular biology of endothelin signal transductionQ33538208
Stimuli of sensory-motor nerves terminate arterial contractile effects of endothelin-1 by CGRP and dissociation of ET-1/ET(A)-receptor complexesQ33598651
Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease.Q33675630
Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discoveryQ33890786
Protein kinase C-induced phosphorylation of Orai1 regulates the intracellular Ca2+ level via the store-operated Ca2+ channel.Q34055973
Animal research: reporting in vivo experiments: the ARRIVE guidelinesQ34116755
Evidence for separate effects of U73122 on phospholipase C and calcium channels in human plateletsQ77596611
Novel mechanism of endothelin-1-induced vasospasm after subarachnoid hemorrhageQ80058632
Endothelin-1 and -2: two amino acids matterQ83618517
Calcitonin gene-related peptide terminates long-lasting vasopressor responses to endothelin 1 in vivoQ84179242
Direct activation of human phospholipase C by its well known inhibitor u73122.Q34160786
Guide to Receptors and Channels (GRAC), 5th editionQ34228968
Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathwaysQ34565134
Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve?Q34660839
Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced hemeQ34720361
Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compoundQ34963488
Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cellsQ35372931
Historical review: EndothelinQ35737648
G-protein-coupled receptor allosterism: the promise and the problem(s).Q35922941
G-protein βγ subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptideQ36153281
Rho kinases in cardiovascular physiology and pathophysiologyQ36399309
The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?Q36510011
Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer.Q36610315
Phospholipase C-delta1 modulates sustained contraction of rat mesenteric small arteries in response to noradrenaline, but not endothelin-1Q36844595
Endothelin receptors and painQ37070713
Vascular Smooth Muscle Cell Signaling Mechanisms for Contraction to Angiotensin II and Endothelin-1.Q37247141
On the potential role of source and species of diacylglycerol in phospholipase-dependent regulation of TRPC3 channelsQ37748394
Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.Q37773544
Pharmacological modulation of diacylglycerol-sensitive TRPC3/6/7 channelsQ37798861
Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca(2+) entry pathwaysQ39302766
Assessment of endothelin-A receptor expression in subcutaneous and orthotopic thyroid carcinoma xenografts in vivo employing optical imaging methods.Q39363342
Guidelines for reporting experiments involving animals: the ARRIVE guidelinesQ39512979
ETA-receptor antagonists or allosteric modulators?Q39761886
Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cellsQ40304029
Activation of native TRPC1/C5/C6 channels by endothelin-1 is mediated by both PIP3 and PIP2 in rabbit coronary artery myocytesQ41864077
Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric arteryQ41867528
Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2.Q41906789
Agonist-dependent modulation of arterial endothelinA receptor functionQ42246404
Involvement of rho-kinase in agonists-induced contractions of arteriosclerotic human arteries.Q43880565
Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbitQ44050284
NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1.Q45205014
The quasi-irreversible nature of endothelin binding and G protein-linked signaling in cardiac myocytes.Q46668488
Functional antagonism between endogenous neuropeptide Y and calcitonin gene-related peptide in mesenteric resistance arteriesQ46868861
Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP.Q47324962
The vasoconstriction induced by endothelin-1 is mediated only by ET(A) receptors in mesenteric small resistance arteries of spontaneously hypertensive rats and Wistar Kyoto rats.Q54145893
Regional effects and clearance of endothelin-1 across pulmonary and splanchnic circulation.Q54273171
G-proteins are involved in contractile responses of isolated mesenteric resistance arteries to agonists.Q54315038
Pinacidil, a new vasodilator: pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertensionQ71142508
Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral arteryQ71606785
Felodipine, an arteriolar dilator with pronounced antihypertensive effectQ72544670
Cardiovascular effects of sympathomimetic bronchodilators; epinephrine, ephedrine, pseudoephedrine, isoproterenol, methoxyphenamine and isoprophenamineQ77151835
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)1199-1209
P577publication date2013-11-01
P1433published inBritish Journal of PharmacologyQ919631
P1476titleEndothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries
P478volume170

Reverse relations

cites work (P2860)
Q92909708Dissecting genetic factors affecting phenylephrine infusion rates during anesthesia: a genome-wide association study employing EHR data
Q26767156Endothelin
Q52950195Endothelin-1 and Endothelin-3 Regulate Endothelin Receptor Expression in Rat Coronary Arteries.
Q28246158Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12
Q38742466Evidence for biased agonists and antagonists at the endothelin receptors

Search more.